Tag Archives: atp

Cancer cells adapt energy needs to spread illness to other organs

Ancient Greek warriors were fed a special diet that better prepared them for the demands of battle on distant fields. Cancer cells that metastasize may do the same thing according to a new study revealing previously unknown differences between cancer cells that continue to grow at the original tumor site, and those that travel to other organs. Given that a cancer cell’s unyielding ability to metastasize is the primary cause of cancer-related death, understanding how they successfully migrate can be lifesaving…

Sneaking drugs into cancer cells before triggering release — ScienceDaily

source : http://www.sciencedaily.com/releases/2014/05/140509110721.htm

Mutant enzyme RECQ4 connected to cancer’s ‘Warburg effect’ — ScienceDaily

source : http://www.sciencedaily.com/releases/2014/04/140417164026.htm

New technique uses ATP as trigger for targeted anti-cancer drug delivery — ScienceDaily

source : http://www.sciencedaily.com/releases/2014/03/140311124200.htm

Researchers find potential new treatment approach for pancreatic cancer

Pancreatic cancer is an aggressive cancer with poor prognosis and limited treatment options and is highly resistant to chemotherapy and radiotherapy. But researchers believe they have found an effective strategy for selectively killing pancreatic cancer while sparing healthy cells which could make treatment more effective. …

Copper intake makes tumors breathe

Copper is a key player in cell growth. In order to proliferate, cells require energy, which they produce and store in the form of a molecule called ATP. Like all cells, tumor cells produce energy in two different ways: respiration, which requires oxygen, and glycolysis, which does not. Of the two, respiration is the more efficient way to make ATP…

Interaction between two leukemia drugs explained

Chronic myeloid leukemia (CML) is a form of blood cancer based on a genetic disorder that leads to the overproduction of white blood cells. Ninety-five percent of affected patients can be treated successfully with the Novartis drug imatinib, also known as Gleevec®. Imatinib is an inhibitor that blocks the ATP-binding site of the tyrosine kinase Abl in affected blood cells, thereby suppressing their overactivity. Consequently, the pathological overproduction of leucocytes is stopped and the blood count normalizes…